Market Overview

Cardiac Resynchronization Therapy Devices 2018: Global Market Outlook Analysis to 2024 -


The "Cardiac
Resynchronization Therapy Devices market: Global Industry Analysis,
Trends, Market Size and Forecasts up to 2024"
report has been
added to's offering.

The report predicts the global cardiac resynchronization therapy devices
market to grow with a CAGR of 7.6% over the forecast period of 2018-2024.

Rising incidence rate of the heart diseases such as sick sinus syndrome,
cardiac arrest, and bradycardia worldwide are driving the growing of CRT
devices market. The demand for invasive techniques in treatment of the
heart diseases is increased and changes in the life style are likely to
boost the growth of this market. Additionally, growing geriatric
patients worldwide is likely to support the growth of the market.

Moreover, technological advancements and rising awareness of the CRT
devices are driving the market of the CRT devices. On the other hand,
surgical site infection, failure in delivering the optimum therapy when
it is needed, sensitivity towards the device material are the risk
associated CRT devices that are likely to hamper the growth of CRT
devices market.

North America is expected to be the largest market for CRT devices,
followed by Europe. There is an intense competition among these regions.
North America accounted for the highest market share owing to presence
of advance healthcare infrastructure in the countries like U.S and
Canada. The demand for advance technology, increasing growth of
geriatric population suffering from cardiac and increasing awareness
concerning the treatment of heart failure dysfunction has boosted the
market in this region.

The U.K. and Germany are the largest revenue generating countries in
Europe region. Moreover, product approval and well established
healthcare infrastructure are expected to drive the growth in the Europe
CRT device market.

Key Topics Covered

1. Preface

2. Executive Summary

3. Global Cardiac Resynchronization Therapy Devices Market Overview

4. Global Cardiac Resynchronization Therapy Devices Market by Product

5. Global Cardiac Resynchronization Therapy Devices Market by Region

6. Companies Covered

  • Medtronic
  • Abbott Laboratories
  • St. Jude Medical
  • LivaNova PLC
  • Boston Scientific
  • Biotronik
  • Cook Group Inc.
  • Johnson & Johnson

For more information about this report visit

View Comments and Join the Discussion!